sure.
but when your first quarter offers 275k in sales and the second offers 11k, as a shareholder i am very concerned.
the problem for me is that my way of thinking is that evolis was going to be a steady flow of revenue for the company as its progresses the big plays ie midkine, elisa etc without diluting it any further.
Ann: Appendix 4C - quarterly , page-6
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AN1 (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $3.690M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 565639 | 0.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.9¢ | 80000 | 1 |
View Market Depth
| Last trade - 16.12pm 03/09/2024 (20 minute delay) ? |
| AN1 (ASX) Chart |
Day chart unavailable